Comparison of hospital length of stay and hospitalization costs among patients with non‐valvular atrial fibrillation treated with apixaban or warfarin: an early view

Abstract Objective: To quantify and compare hospital length of stay (LOS) and costs between hospitalized non-valvular atrial fibrillation (NVAF) patients treated with either apixaban or warfarin via a large claims database. Methods: Adult patients hospitalized with AF...

Comparison of real‐world adherence, health care resource utilization and costs for newly initiated valsartan/amlodipine single‐pill combination vs angiotensin‐receptor blocker/calcium‐channel blocker free combination therapy

Abstract Authors: Baser O, Andrews LM, Wang L, Xie L. Objective: To compare adherence, healthcare costs and utilization of valsartan/amlodipine single-pill combination (SPC) and angiotensin-receptor blocker/calcium-channel blocker multiple-pill free-combination...